T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

Researchers in upstate New York are hopeful the work they’re doing may soon lead to new therapies for more cancer ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as ...

For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized ...

For women age 70 and over with a common form of breast cancer, determining “the right size” of treatment can be challenging, in part because clinicians have limited tools to guide ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

KTALnews.com (KTAL/KMSS) – With March being National Colorectal Cancer Awareness Month, there’s never been a better time to screen for the disease. CRC is the 2nd-leading cause of cancer deaths in the ...